ArticleBMC health services research2022

Cost-effectiveness analysis of dasatinib versus imatinib in pediatric philadelphia chromosome-positive acute lymphoblastic leukemia patients in China.

Wang Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.